5Roy SH, Alan BS. Non-small cell lung cancer and antiangiogenic therapy: what can he expected Bevacizumah. Oncologist, 2004,9(Suppl 1) : 19-26.
6Tracy EK,John RM. Therapy for stage Ⅲ A,Ⅲ B and Ⅳ non-small cell lung cancer. Clin Pulm Med,2004,11 (3) : 161-174.
7Dupont J, Schwartz L, Koutcher J, et al. Phase Ⅰ and pharmacokinetic study of VEGF Trap administered subcutaneously (sc) to patients (pts) with advanced solid malignancies. J Clin Oncol, 2004,22 ( 14 Suppl) : 3009-3009.
8Lee ME. Epidermal growth factor receptor in tumor angiogenesis. Hematol Oncol Clin N Am, 2004, 18 (5) : 1007-1021.
9O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell, 1994,79 (2) :315-328.
10Sung PJ,Brett S,Wang YZ,et al. Effect of human angiostatin protein on human angiogenesis in vitro. Angiogenesis, 2003, 6(3) :233-240.
9Wei YQ, Wang QR, Zhao X, et al.hnmunotherapy of tumors with xenogeneic endothelial cells as a vaccine [J]. Nat Med, 2000, 6: 1160-1166.
10Yoneyarna, Y. Okaji, N.H. Tsuno, et al. A study of dendritic and endothelial cell interactions in colon cancer in a cell line and small mammal model [J]. Eur J Surg Oncol, 2007, 33 (10) : 1191- 1198.
